Brendel E - Search Results

1

Lack of drug-drug interaction between cerivastatin and nifedipine.

Sachse R, Brendel E, Mück W, Rohde G, Ochmann K, Horstmann R, Kuhlmann J. Sachse R, et al. Among authors: brendel e. Int J Clin Pharmacol Ther. 1998 Aug;36(8):409-13. Int J Clin Pharmacol Ther. 1998. PMID: 9726692 Clinical Trial.

2

Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.

Brendel E, Weimann B, Dietrich H, Froede C, Thomas D. Brendel E, et al. Int J Clin Pharmacol Ther. 2013 Sep;51(9):753-62. doi: 10.5414/CP201879. Int J Clin Pharmacol Ther. 2013. PMID: 23849325 Clinical Trial.

3

Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.

Schug BS, Brendel E, Wolf D, Wonnemann M, Wargenau M, Blume HH. Schug BS, et al. Among authors: brendel e. Eur J Pharm Sci. 2002 Apr;15(3):279-85. doi: 10.1016/s0928-0987(02)00008-8. Eur J Pharm Sci. 2002. PMID: 11923060 Clinical Trial.

4

Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.

Wonnemann M, Schug B, Anschütz M, Brendel E, De Nucci G, Blume H. Wonnemann M, et al. Among authors: brendel e. Clin Ther. 2008 Jan;30(1):48-58. doi: 10.1016/j.clinthera.2008.01.001. Clin Ther. 2008. PMID: 18343242 Clinical Trial.

5

Pharmacokinetics and safety of nifedipine GITS/candesartan fixed-dose combination in subjects with hepatic impairment .

Liu Y, Boettcher MF, Schmidt A, Unger S, Halabi A, Brendel E, Blode H. Liu Y, et al. Among authors: brendel e. Int J Clin Pharmacol Ther. 2017 Mar;55(3):246-255. doi: 10.5414/CP202700. Int J Clin Pharmacol Ther. 2017. PMID: 28025965 Clinical Trial.

6

Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.

Ahr HJ, Boberg M, Brendel E, Krause HP, Steinke W. Ahr HJ, et al. Among authors: brendel e. Arzneimittelforschung. 1997 Jun;47(6):734-45. Arzneimittelforschung. 1997. PMID: 9239452 Clinical Trial.

7

Pharmacokinetic interactions of nifedipine and quinidine.

Hippius M, Henschel L, Sigusch H, Tepper J, Brendel E, Hoffmann A. Hippius M, et al. Among authors: brendel e. Pharmazie. 1995 Sep;50(9):613-6. Pharmazie. 1995. PMID: 7480098 Clinical Trial.

8

Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.

Anschütz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, Pauli K, Brendel E, Blume H. Anschütz M, et al. Among authors: brendel e. Int J Clin Pharmacol Ther. 2010 Feb;48(2):158-70. doi: 10.5414/cpp48158. Int J Clin Pharmacol Ther. 2010. PMID: 20137768 Clinical Trial.

9

Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.

Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H. Wonnemann M, et al. Among authors: brendel e. Int J Clin Pharmacol Ther. 2006 Jan;44(1):38-48. doi: 10.5414/cpp44038. Int J Clin Pharmacol Ther. 2006. PMID: 16425970 Clinical Trial.

10

Loss of blood pressure control on withdrawal of fluconazole during nifedipine therapy.

Kremens B, Brendel E, Bald M, Czyborra P, Michel MC. Kremens B, et al. Among authors: brendel e. Br J Clin Pharmacol. 1999 Jun;47(6):707-8. doi: 10.1046/j.1365-2125.1999.00965.x. Br J Clin Pharmacol. 1999. PMID: 10438200 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results